Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lupus

Showing results (981-990 of 5,623) with videos related to

Pageof 563
Sort By:
Lupus|December 17, 2008
Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adultsK B Onel, D Huo, D Hastings, et al.
Lupus|December 17, 2008
Anti-double stranded DNA and lupus syndrome induced by interferon-beta therapy in a patient with multiple sclerosisB Bonaci-Nikolic, I Jeremic, S Andrejevic, et al.
Lupus|January 20, 2009
Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter studyF Falcini, S Capannini, G Martini, et al.
Lupus|January 20, 2009
Complementary or alternative therapy use and health status in systemic lupus erythematosusJ Alvarez-Nemegyei, A Bautista-Botello
Lupus|November 1, 2007
Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patientsS Malik, G R Bruner, C Williams-Weese, et al.
Lupus|November 1, 2007
Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejectionS-J Li, Z-H Liu, C-H Zen, et al.
Lupus|November 1, 2007
Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot studyH Tanaka, E Oki, K Tsugawa, et al.
Lupus|August 1, 2007
Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damageA M Bertoli, L M Vila, M Apte, et al.
Lupus|August 1, 2007
MTR 2756 A > G polymorphism is associated with the risk of systemic lupus erythematosus in the Polish populationM Burzynski, S Duriagin, M Mostowska, et al.
Lupus|August 3, 2007
Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodiesG Castellino, F Corallini, F Trotta, et al.
Pageof 563

Showing results (981-990 of 5,623) with videos related to

Sort By:
Pageof 563
Lupus|December 17, 2008
Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adultsK B Onel, D Huo, D Hastings, et al.
Lupus|December 17, 2008
Anti-double stranded DNA and lupus syndrome induced by interferon-beta therapy in a patient with multiple sclerosisB Bonaci-Nikolic, I Jeremic, S Andrejevic, et al.
Lupus|January 20, 2009
Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter studyF Falcini, S Capannini, G Martini, et al.
Lupus|January 20, 2009
Complementary or alternative therapy use and health status in systemic lupus erythematosusJ Alvarez-Nemegyei, A Bautista-Botello
Lupus|November 1, 2007
Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patientsS Malik, G R Bruner, C Williams-Weese, et al.
Lupus|November 1, 2007
Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejectionS-J Li, Z-H Liu, C-H Zen, et al.
Lupus|November 1, 2007
Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot studyH Tanaka, E Oki, K Tsugawa, et al.
Lupus|August 1, 2007
Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damageA M Bertoli, L M Vila, M Apte, et al.
Lupus|August 1, 2007
MTR 2756 A > G polymorphism is associated with the risk of systemic lupus erythematosus in the Polish populationM Burzynski, S Duriagin, M Mostowska, et al.
Lupus|August 3, 2007
Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodiesG Castellino, F Corallini, F Trotta, et al.
Pageof 563